XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.23.1

Business Segments | 9 Months Ended
--- | ---
Mar. 31, 2023
Business Segments |
Business Segments | 10. Business Segments We evaluate performance and allocate resources, based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate includes certain costs related to executive management, business technology, legal, finance, human resources and business development. We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, and (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and certain items that we consider to be unusual, non-operational or non-recurring. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Nine Months
For the Periods Ended March 31 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 164,434 | ​ | $ | 148,589 | ​ | $ | 483,096 | ​ | $ | 440,520
Mineral Nutrition | ​ |  | 62,922 | ​ |  | 69,033 | ​ |  | 184,212 | ​ |  | 190,120
Performance Products | ​ |  | 18,317 | ​ |  | 21,997 | ​ |  | 55,532 | ​ |  | 56,356
Total segments | ​ | $ | 245,673 | ​ | $ | 239,619 | ​ | $ | 722,840 | ​ | $ | 686,996
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 6,888 | ​ | $ | 6,935 | ​ | $ | 20,733 | ​ | $ | 19,872
Mineral Nutrition | ​ |  | 671 | ​ |  | 661 | ​ |  | 1,985 | ​ |  | 1,960
Performance Products | ​ |  | 453 | ​ |  | 436 | ​ |  | 1,348 | ​ |  | 1,292
Total segments | ​ | $ | 8,012 | ​ | $ | 8,032 | ​ | $ | 24,066 | ​ | $ | 23,124
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 34,217 | ​ | $ | 29,232 | ​ | $ | 98,240 | ​ | $ | 90,565
Mineral Nutrition | ​ |  | 3,859 | ​ |  | 7,303 | ​ |  | 13,555 | ​ |  | 17,361
Performance Products | ​ |  | 2,413 | ​ |  | 2,865 | ​ |  | 7,069 | ​ |  | 6,327
Total segments | ​ | $ | 40,489 | ​ | $ | 39,400 | ​ | $ | 118,864 | ​ | $ | 114,253
Reconciliation of income before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before income taxes | ​ | $ | 15,104 | ​ | $ | 26,833 | ​ | $ | 32,630 | ​ | $ | 59,958
Interest expense, net | ​ |  | 3,871 | ​ |  | 2,925 | ​ |  | 10,822 | ​ |  | 8,767
Depreciation and amortization – Total segments | ​ |  | 8,012 | ​ |  | 8,032 | ​ |  | 24,066 | ​ |  | 23,124
Depreciation and amortization – Corporate | ​ |  | 477 | ​ |  | 413 | ​ |  | 1,372 | ​ |  | 1,176
Corporate costs | ​ | ​ | 13,122 | ​ | ​ | 11,404 | ​ | ​ | 38,451 | ​ | ​ | 34,699
Environmental remediation costs | ​ | ​ | 325 | ​ | ​ | — | ​ | ​ | 6,894 | ​ | ​ | —
Gain on sale of investment | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,203)
Acquisition-related cost of goods sold | ​ |  | — | ​ |  | 78 | ​ |  | — | ​ |  | 78
Acquisition-related transaction costs | ​ |  | — | ​ |  | 279 | ​ |  | — | ​ |  | 279
Foreign currency (gains) losses, net | ​ |  | (422) | ​ |  | (10,564) | ​ |  | 4,629 | ​ |  | (12,625)
Adjusted EBITDA – Total segments | ​ | $ | 40,489 | ​ | $ | 39,400 | ​ | $ | 118,864 | ​ | $ | 114,253
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, |  | June 30,
As of |  | 2023 |  | 2022
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 686,510 | ​ | $ | 654,862
Mineral Nutrition | ​ |  | 91,205 | ​ |  | 87,379
Performance Products | ​ |  | 47,522 | ​ |  | 39,490
Total segments | ​ |  | 825,237 | ​ |  | 781,731
Corporate | ​ |  | 140,195 | ​ |  | 149,968
Total | ​ | $ | 965,432 | ​ | $ | 931,699
​ The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, interest rate swap agreement, debt issuance costs, income tax-related assets and certain other assets.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration